Nanollose Limited (ASX: NC6)
Health Care · Biotechnology · AU
AU$0.08
-1.30% today · +52.0% 1Y
Nanollose Limited (ASX: NC6) operates in the Biotechnology industry within the Health Care sector. The company is valued at $21.63M and employs 1 people.
Over the last twelve months the share price has gained 52.0%, trading between 0.04 and 0.08.
Tweenvest scores Nanollose Limited across four factors: quality 35/100, value 63/100, growth 26/100. Its strongest factor is value.
NC6 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.63M
- Revenue (TTM)
- $215.19K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- AU$0.08
- 52-week low
- AU$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 408.95M
- Employees
- 1
- Next earnings
- —
About Nanollose Limited
Nanollose Limited is an Australian biomaterials enterprise dedicated to the research, development, and commercialization of microbial nanocellulose technology. Its product line features Nullarbor Fibre, an innovative lyocell fibre produced without relying on trees, and Jelli Grow, an eco-friendly substitute for seed germination and cultivating plants. These materials find applications across various sectors, including textiles, nonwoven fabrics, and other industries. Established in 2014, the company's headquarters are situated in Nedlands, Australia.
- ISIN
- AU000000NC68
- Founded
- 2014
- Listed since
- Oct 17, 2017
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Grace Breeding LtdTASE: GRAC | $22.64M | ₪16.47 | +1.92% |
| Arterra Bioscience S.p.A.BIT: ARBS | $22.59M | €3.03 | +0.33% |
| MaaT Pharma SAENXTPA: MAAT | $22.54M | €1.07 | +0.56% |
| genOway Société anonymeENXTPA: ALGEN | $22.30M | €2.15 | -3.59% |
| Helyx Industries S.p.A.BIT: HLX | $20.77M | €0.70 | -7.67% |
| SkinBioTherapeutics plcAIM: SBTX | $20.74M | £0.06 | +12.15% |
| APTOCROM Inc.KOSDAQ: A109960 | $20.66M | ₩1,821.00 | -5.50% |
| ProBiotix Health PlcOFEX: PBX | $20.57M | £0.10 | +2.63% |
Figures last refreshed Oct 18, 2026.